Featured

Sanofi's SAR446523 Receives Orphan Drug Designation for Multiple Myeloma

Sanofi announced that the FDA granted orphan drug designation to SAR446523, a monoclonal antibody targeting GPRC5D, for the treatment of relapsed or r...

Home/KnolSights/Regulatory Approvals/Sanofi's SAR446523 Receives Orphan Drug Designation for Multiple Myeloma